Is the Cure Worse than the Disease? Caveats in the Move from Laboratory to Clinic
- 12 November 2008
- journal article
- review article
- Published by Wiley in Developmental Medicine and Child Neurology
- Vol. 34 (11) , 1015-1018
- https://doi.org/10.1111/j.1469-8749.1992.tb11408.x
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Suppression of postischemic epileptiform activity with MK‐801 improves neural outcome in fetal sheepAnnals of Neurology, 1992
- A role for IGF-1 in the rescue of CNS neurons following hypoxic-ischemic injuryBiochemical and Biophysical Research Communications, 1992
- Flunarizine, a Calcium Channel Antagonist, Is Not Neuroprotective when Given after Hypoxia-Ischemia in the Infant RatDevelopmental Pharmacology and Therapeutics, 1991
- Time course of intracellular edema and epileptiform activity following prenatal cerebral ischemia in sheep.Stroke, 1991
- Cerebral hypoxia: some new approaches and unanswered questionsJournal of Neuroscience, 1990
- Effect of hyperglycemia on neuronal changes in a rabbit model of focal cerebral ischemia.Stroke, 1990
- The Neuroprotective Actions of a Calcium Channel Antagonist, Flunarizine, in the Infant RatPediatric Research, 1989
- The excitatory amino acid antagonist kynurenic acid administered after hypoxic-ischemia in neonatal rats offers neuroprotectionNeuroscience Letters, 1988
- Ischemia in normo- and hyperglycemic rats: effects on brain water and electrolytes.Stroke, 1987
- Flunarizine limits hypoxia-ischemia induced morphologic injury in immature rat brain.Stroke, 1986